期刊文献+

肺虚痰阻证模型大鼠肺组织水通道蛋白1和5分子表达与补肺化痰方对其影响(英文)

Effects of Compound Herbal Formulary on Expression of Aquaporin 1 andAquaporin 5 in the Model of Rats with Phlegm Obstruction Due toLung-Deficiency Syndromes
原文传递
导出
摘要 目的:1)从肺泡上皮水主动转运功能的角度探讨肺虚痰阻证的发生机理。2)通过观察肺虚痰阻证模型的AQP的活性及其相关基因、蛋白的表达和补肺化痰中药复方治疗前、后的对比,观察这一过程中上述指标的变化情况。方法:将雄性SD大鼠随机分为正常组、模型组、中药治疗组。模型组和治疗组造模40天,治疗组在造模26天后,药物灌胃治疗2周。采用组织化学染色法,对大鼠肺进行病理分析;RT-PCR的方法检测大鼠肺组织中AQP1、AQP5基因表达;western blot法检测大鼠肺组织中AQP1、AQP5蛋白水平。结果:1)与正常组相比,模型组局部出现明显炎症反应(P<0.01),治疗组局部炎症反应减轻(P<0.05)。2)mRNA结果显示,AQP1在正常组有表达,在模型组和治疗组未见表达。AQP5模型组与正常组相比,表达量显著增高(P<0.01);治疗组与模型组比较,表达量显著降低(P<0.01),但与正常组无显著差异。3)蛋白水平上,AQP1在模型组和治疗组与正常组相比差异显著(P<0.05),表达下降。AQP5模型组与正常组相比,显著升高(P<0.01);治疗组与模型组比较,显著下调(P<0.05);正常组表达低于治疗组,差异显著(P<0.05)。结论:1)AQP1和5基因及蛋白表达量变化是肺虚痰阻证的病理机制之一。2)补肺化痰中药复方可调节肺虚痰阻证模型大鼠肺组织AQP 5基因及蛋白表达。提示补肺化痰中药复方治疗肺虚痰阻证其作用机制与调节AQP5有关。 Objective: 1)To investigate the formative mechanism of phlegm obstruction due to lung-deficiency syndromes.2) To investigate the dynamic changes of the above parameters by detecting the effects of the herbal compound that "invigorates the lung and promotes expectorant" on the expression of AQP1 and AQP5 in the phlegm obstruction due to lung-deficiency syndromes model rats.Methods: Male SD Rats were randomly divided into three groups: normal,model,and treatment(with herbal Rats were treated by "invig-orate lung expectorant" herbal compound).The pathologic changes of lung were analyzed by microscopy with HE staining.The mRNA and protein expressions of AQP1 and AQP5 were assayed by semi-quantitative RT-PCR and western blot respectively.Results: There was no expression of AQP1 mRNAs in the model and treated groups,while the expression of AQP5 mRNAs increased in the model group.Western blot analysis showed similar patterns of AQP5 protein being upregulated(P0.01) while AQP1 downregulated(P0.05).The expression of the AQP5 protein in the treated group decreased compared with that in the normal group(P0.05).Conclusions: 1) One of the pathological mechanisms of the syndrome of "phelgm obstuction due to lung deficiency" is caused by the up-regulation of AQP5 and down-regulation of AQP1 gene and protein expression in lungs of the alveolar epithelium of rats.2) The expectorant herbal compound treatment can regulate the gene and protein expression of AQP5 but can't regulate the AQP1 when the rats have this desease.These results suggest that the mechanism of this compound acting on this desease is related to the regulation of the expression of AQP1 AQP5.
出处 《现代生物医学进展》 CAS 2012年第1期30-35,共6页 Progress in Modern Biomedicine
基金 National Natural Science Foundation of China(30772687) Natural Science Foundation of Guangdong province(9251040701000001)~~
关键词 AQP1 AQP5 大鼠肺 肺虚痰阻证 补肺化痰中药复方 AQP1 AQP5 Rat lung Phlegm obstruction due to lung-deficiency syndromes Invigorate lung expectorant complex
  • 相关文献

参考文献5

二级参考文献31

  • 1张泓,孙耕耘.血管紧张素Ⅱ及其受体拮抗剂对大鼠肺微血管内皮炎性损伤效应的影响[J].中国危重病急救医学,2004,16(10):608-610. 被引量:16
  • 2李晶铃,阴赪宏,王超,文艳,张淑文,王宝恩.内毒素血症时循环肾素-血管紧张素系统改变的实验研究[J].中国危重病急救医学,2006,18(2):92-95. 被引量:20
  • 3王九林,姜惟,卞慧敏,杨进,王耿,周学胜.肺虚痰阻病理模型的研制[J].中国中医基础医学杂志,1996,2(4):44-45. 被引量:12
  • 4贝政平.3200个内科疾病诊断标准[M].北京:科学出版社,1998.631-632.
  • 5国家中医药管理局.中华人民共和国中医药行业标准[M].南京大学出版社,1994.6,28,187.
  • 6CW迪芬巴赫 等 黄培堂等(译).PCR技术实验指南[M].北京:科学出版社,1998,8..
  • 7汤键 周爱儒.原癌基因与心血管疾病[M].北京:北京医科大学,中国协和医科大学联合出版社,1990.165.
  • 8贝政平.3 200个内科疾病诊断标准[M].北京:科学出版社,1998.49-53.
  • 9Borok Z,Verkman AS.Lung edema clearance:20 years of progress:invited review:role of aquaporin water channels in fluid transport in lung and airways.J Appl Physiol,2002,93:2199-2206.
  • 10Marshall RP.The pulmonary renin-angiotensin system.Curr Pharm Des,2003,9:715-722.

共引文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部